Prognostic value of phospholipase A2 group II, C-reactive protein and simplified acute physiological score II in intensive care patients

Clinical Laboratory

Volumn 52, Issue 7-8, 2006, Pages 387-392

  Dajak, Marijana ^a   Ignjatović, Svetlana ^b   Majkić Singh, Nada ^b   Laušević, Željko ^a   Bukumirović, Vesna ^b  

^a University Clinic Centre   (Yugoslavia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

CRP; Inflammation; Multiple injuries; Phospholipase A2; PLA2 II; Prognosis; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; PHOSPHOLIPASE A2;

ACINETOBACTER CALCOACETICUS; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYSTALLOID; DEATH; DISEASE SEVERITY; ELECTIVE SURGERY; EMERGENCY SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUID THERAPY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INTENSIVE CARE; INTENSIVE CARE UNIT; MALE; MEDICAL ASSESSMENT; MULTIPLE TRAUMA; OUTCOME ASSESSMENT; PATIENT CODING; PREDICTION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL DRAINAGE; SURVIVAL RATE;

ADULT; AGED; AREA UNDER CURVE; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PHOSPHOLIPASES A; PROGNOSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33748367425     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Marshall JC, Vincent JL, Fink MP, et al. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 2003; 31: 1560-7.
2. Harbath S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.
3. Rintala EM, Aittoniemi J, Laine S, Nevalainen TJ, Nikoskelainen J. Early identification of bacteraemia by biochemical markers of systemic inflammation. Scand J Clin Lab Invest 2001; 61: 523-30.
4. Rintala E, Peuravuori H, Pulkki K, Voipio-Pulkki LM, Nevalainen T. Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome. Intensive Care Med 2000; 26: 1248-51.
5. Carrigan SD, Scott G, Tabrizian M. Toward resolving the challenges of sepsis diagnosis. Clin Chem 2004; 50: 1301-14.
6. Keel M, Ecknauer E, Stocker R, et al. Different pattern of local and systemic release of pro-inflammatory and anti-inflammatory mediators in severely injured patients with chest trauma. J Trauma 1996; 40: 907-12.
7. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horizons 1993; 1: 538-49.
8. Strecker W, Gebhard F, Perl M, et al. Biochemical characterization of individual injury pattern and injury severity. Injury, Int J Care Injured 2003; 34: 879-87.
9. Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Bruckner UB. Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg 2000; 135: 291-5.
10. Lo YMD, Rainer TH, Chan LYS, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000; 46: 319-23.
11. Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185-8.
12. Hietaranta A, Kemppainen E, Puolakkainen P, et al. Extracellular phospholipase A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis. Pancreas 1999; 18: 385-91.
13. Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001; 27: 211-5.
14. Oconnor E, Venkatesh B, Mashongonyika C, Lipman J, Hall J, Thomas P. Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage. Anaesth Intensive Care 2004; 32: 465-70.
15. Oberhoffer M, Vogelsang H, Russwurm S, Hartung T, Reinhart K. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999; 37: 363-8 Erratum in: Clin Chem Lab Med 1999; 37: 697.
16. Nevalainen T. Serum phospholipase A2 in inflammatory diseases. Clin Chem 1993; 39: 2453-9.
17. Nakae H, Endo S, Inada K, et al. Nitrate/nitrite (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 1996; 92: 131-9.
18. Guidet B, Piot O, Masliah J, et al. Secretory nonpancreatic phospholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2. Infection 1996; 24: 103-8.
19. Nyman K, Uhl W, Forsstrom J, Buchler M, Beger H, Nevalainen T. Serum phospholipase A2 in patients with multiple organ failure. J Surg Res 1996; 60: 7-14.
20. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-55.
21. American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee. Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
22. Le Gall JR., Lemeshow S, Sauliner F. A new Simplified Acute Physiology Score (SAPS II) based on a European-North American multicenter study. JAMA 1993; 270: 2967-73.
23. Dajak M, Ignjatović S, Majkić-Singh N. Scoring systems as prognostic markers in intensive care patients. Jugoslov Med Biochem 2003; 22 (Suppl 2): 186.
24. Kairisto V, Poola A. Software for illustrative presentation of basic clinical characteristics of laboratory tests - GraphRoc for Windows. Scand J Clin Lab Invest 1995; Suppl 222: 43-60.
25. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine [Review]. Clin Chem 1993; 39: 561-77.
26. Weinrauch Y, Abad C, Liang NS, Lowry SF, Weiss J. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group II phospholipase A2. J Clin Invest 1998; 102: 633-8.